Methamphetamine (MA) and related stimulant abuse remains a major public health concern globally. MA addiction is a highly complicated neuropathological disorder that recruits multiple brain regions and neurotransmitter systems. Despite decades of research, no effective pharmacotherapy has yet been developed for treating MA addiction. Imidazoline I2 receptors may represent a novel target for developing pharmacotherapy of drug addiction. Accumulating evidence indicates that I2 receptor agonists can modulate the dopaminergic system and behavioral studies have demonstrated the attenuation of the addiction-related effects of opioids by the endogenous imidazoline receptor ligand agmatine. However, little is known of whether pharmacologically selective I2 receptor ligands modulate the addiction-related effects of drugs of abuse. We recently observed that a selective I2 receptor agonist, 2-BFI, markedly attenuates MA induced behavioral sensitization and conditioned place preference. The objective of the present application is to evaluate the proof-of-concept that the I2 receptor is a novel drug target for the treatment of MA addiction. Guided by exciting preliminary data, this hypothesis will be tested by pursuing two specific aims: 1) examine the effect of an I2 receptor agonist, 2-BFI, and an antagonist, tracizoline, on the development and reinstatement of MA-induced conditioned place preference (Aim 1);2) examine the interaction between I2 receptor ligands and MA in animals discriminating MA or the I2 receptor agonist, 2-BFI, using a drug discrimination procedure (Aim 2). Collectively, the proposed studies systematically evaluate the effects of I2 receptor ligands on the addiction- related (e.g., rewarding and discriminative stimulus) effects of MA. These data will provide valuable information regarding the potential therapeutic value of I2 receptor agonists for the treatment of addiction to MA and related stimulants. In addition, data obtained in the proposed investigation may contribute to the identification of further novel I2 receptor based pharmacotherapies for addiction to MA.

Public Health Relevance

Methamphetamine abuse and addiction remains a significant public health challenge and effective pharmacotherapy is lacking. This application explores the potential therapeutic value of imidazoline I2 receptor agonists for methamphetamine addiction. The proposed research is relevant to the part of NIH's mission that may identify novel pharmacotherapies to help combat methamphetamine addiction.

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Exploratory/Developmental Grants (R21)
Project #
Application #
Study Section
Biobehavioral Regulation, Learning and Ethology Study Section (BRLE)
Program Officer
Hillery, Paul
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
State University of New York at Buffalo
Schools of Medicine
United States
Zip Code
Jing, Li; Zhang, Min; Li, Jun-Xu et al. (2014) Comparison of single versus repeated methamphetamine injection induced behavioral sensitization in mice. Neurosci Lett 560:103-6
Qiu, Yanyan; Thorn, David A; Zhang, Yanan et al. (2014) Behavioral effects of the imidazoline I(2) receptor ligand BU99006 in rats. Behav Pharmacol 25:130-6
Ding, Yuanyuan; Qiu, Yanyan; Jing, Li et al. (2014) Behavioral effects of the cannabinoid CB1 receptor allosteric modulator ORG27569 in rats. Pharmacol Res Perspect 2:e00069
Li, Yu-Ling; Liu, Qing; Gong, Qi et al. (2014) Brucine suppresses ethanol intake and preference in alcohol-preferring Fawn-Hooded rats. Acta Pharmacol Sin 35:853-61
Thorn, David A; Jing, Li; Qiu, Yanyan et al. (2014) Effects of the trace amine-associated receptor 1 agonist RO5263397 on abuse-related effects of cocaine in rats. Neuropsychopharmacology 39:2309-16
Kong, Wei-Lin; Min, Jia-Wei; Liu, Yuan-Lin et al. (2014) Role of TRPV1 in susceptibility to PTZ-induced seizure following repeated hyperthermia challenges in neonatal mice. Epilepsy Behav 31:276-80
Li, Jun-Xu; Thorn, David A; Qiu, Yanyan et al. (2014) Antihyperalgesic effects of imidazoline I(2) receptor ligands in rat models of inflammatory and neuropathic pain. Br J Pharmacol 171:1580-90
Li, Jun-Xu (2014) Trace amines and cocaine abuse. ACS Chem Neurosci 5:497-8
Thorn, David A; Zhang, Chaogui; Zhang, Yanan et al. (2014) The trace amine associated receptor 1 agonist RO5263397 attenuates the induction of cocaine behavioral sensitization in rats. Neurosci Lett 566:67-71
Qiu, Yanyan; He, Xiao-Hua; Zhang, Yanan et al. (2014) Discriminative stimulus effects of the novel imidazoline I? receptor ligand CR4056 in rats. Sci Rep 4:6605

Showing the most recent 10 out of 12 publications